1. Clinical & Scientific Overview
Allantoin (TIP-MED-000617, Reference Code [COS-13]) is classified under
Cosmetics & Cosmeceutical Ingredients (Cosmetics Rules, 2020) as a Cosmetic Science & Dermopharmaceutics • Keratolytic-Soothing & Skin-Protecting Imidazolidine Derivative.
Within the Indian regulatory and compendial framework, it is governed under Cosmetic skin protectant/conditioner under Cosmetics Rules, 2020..
INCI Standard: Allantoin (IS 4707 / Cosmetics Rules, 2020 Compliant)
0.1% to 0.5% in aqueous phases (up to 2.0% in suspended barrier creams); pH 4.0–8.0
Dermopharmaceutics, INCI Formulation & Cosmetics Rules 2020 Compliance
AllantoinKeratolytic-Soothing & Skin-Protecting Imidazolidine Derivative
0.1% to 0.5% in aqueous phases (up to 2.0% in suspended barrier creams); pH 4.0–8.0
Irritation, Sensitisation & Photoprotection Considerations: Non-toxic and non-sensitising; however, water solubility at room temperature is limited to ~0.5% — concentrations above 0.5% un-solubilised can recrystallize into sharp microscopic needles if heated and cooled improperly!
Chemical Stability & Formulation Incompatibilities: Add below 50°C during cool-down or use allantoin-panthenol complexes; decomposes in strong alkalis (pH >8.5).
Statutory Cosmetic vs Drug Distinction (Cosmetics Rules, 2020 & BIS IS 4707): Cosmetic skin protectant/conditioner under Cosmetics Rules, 2020.
3. Mechanism of Action & Pharmacodynamics
Increases water binding capacity of the extracellular matrix, gently loosens desquamating corneocytes, and complexes with sensitising surfactant molecules to reduce irritation.
4. Therapeutic Indications & Evidence-Supported Uses
- Soothing sensitive, shaved, or chapped skin and diaper-area barrier creams
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Cosmetic Formulation Concentration & pH Window: 0.1% to 0.5% in aqueous phases (up to 2.0% in suspended barrier creams); pH 4.0–8.0
Administration & Meal Timing: External topical use only (0.1% to 0.5% in aqueous phases (up to 2.0% in suspended barrier creams); pH 4.0–8.0). Add below 50°C during cool-down or use allantoin-panthenol complexes; decomposes in strong alkalis (pH >8.5).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Stratum corneum partitioning and epidermal retention governed by molecular weight (<500 Da rule), logP, and formulation pH; cosmetic ingredients are formulated for local epidermal/corneocyte conditioning without systemic pharmacological action.
Local epidermal enzymatic hydrolysis or oxidation where applicable (e.g., esterases for retinyl/tocopheryl esters).
Not applicable (topical cosmetic ingredient with negligible systemic exposure when used on intact skin).
Not applicable (topical external cosmetic use).
7. Contraindications, Precautions & High-Risk Warnings
- Known allergic contact dermatitis or hypersensitivity to Allantoin
- Application to open wounds, abraded skin, or acute infectious dermatoses
- Non-toxic and non-sensitising; however, water solubility at room temperature is limited to ~0.5% — concentrations above 0.5% un-solubilised can recrystallize into sharp microscopic needles if heated and cooled improperly!
Key Clinical Precautions: Non-toxic and non-sensitising; however, water solubility at room temperature is limited to ~0.5% — concentrations above 0.5% un-solubilised can recrystallize into sharp microscopic needles if heated and cooled improperly!
8. Adverse Effects Profile
- Non-toxic and non-sensitising; however, water solubility at room temperature is limited to ~0.5% — concentrations above 0.5% un-solubilised can recrystallize into sharp microscopic needles if heated and cooled improperly!
- Non-toxic and non-sensitising; however, water solubility at room temperature is limited to ~0.5% — concentrations above 0.5% un-solubilised can recrystallize into sharp microscopic needles if heated and cooled improperly!
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Add below 50°C during cool-down or use allantoin-panthenol complexes; decomposes in strong alkalis (pH >8.5).
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Formulation Stability & Compatibility Check: Add below 50°C during cool-down or use allantoin-panthenol complexes; decomposes in strong alkalis (pH >8.5).
Pharmacist Patient Counselling Points:
- Perform a 24–48 hour forearm patch test before introducing a new active cosmeceutical onto facial skin.
- Apply broad-spectrum SPF 30+ PA+++ sunscreen every morning, especially when using AHAs, BHAs, retinol, or brightening actives.
- Cosmetic products clean, condition, or protect superficial skin appearance; persistent acne, melasma, rosacea, or eczema requires medical dermatology evaluation.
Storage, Stability & Dispensing Safeguards: Add below 50°C during cool-down or use allantoin-panthenol complexes; decomposes in strong alkalis (pH >8.5).
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Cosmetics Rules, 2020 (CDSCO, Ministry of Health & Family Welfare, Govt. of India); Bureau of Indian Standards (BIS) IS 4707 (Part 1 & Part 2) Classification of Cosmetic Raw Materials and Adjuncts.
Official Verification Portals: CDSCO — Cosmetics Division & Cosmetics Rules, 2020 • Bureau of Indian Standards (BIS) — IS 4707 Cosmetic Standards
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [COS-10] Kojic Acid / Kojic Acid Dipalmitate — Cosmetic Science & Dermopharmaceutics • Fungal Metabolite Copper-
- [COS-11] Ceramide NP (Ceramide III) & Barrier Lipids — Cosmetic Science & Dermopharmaceutics • Skin-Identical Sphingolip
- [COS-12] D-Panthenol (Provitamin B5) — Cosmetic Science & Dermopharmaceutics • Humectant, Emollient & Ke
- [COS-14] Zinc Oxide (Mineral UV Filter & Soothing Protectant) — Cosmetic Science & Dermopharmaceutics • Broad-Spectrum Inorganic
